Book List: pharmaceutical patent

Praxis Pharmaceuticals signs major developmental agreement.: An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News Alnylam and Cenix enter into RNAi research service agreement.(Alnylam Pharmaceuticals, Inc.)(Cenix BioScience GmbH): An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News Determinants of opposition against EPO patent grants-the case of biotechnology and pharmaceuticals [An article from: International Journal of Industrial Organization] Offer Price: USD $8.95 Author: D. Harhoff Publisher: Elsevier La Jolla Pharmaceutical receives Riquent composition of matter patents in Europe and China.: An article from: BIOTECH Patent News Offer Price: USD $9.95 Author: Gale Reference Team Publisher: Thomson Gale BRAZIL BREAKS HIV-DRUG PATENT AFTER FAILED NEGOTIATIONS WITH PHARMACEUTICAL GIANT MERCK.: An article from: NotiSur - South American Political and Economic Affairs Offer Price: USD $9.95 Author: Gale Reference Team Publisher: Thomson Gale Data visualisation tools-a perspective from the pharmaceutical industry [An article from: World Patent Information] Offer Price: USD $5.95 Author: J. Eldridge Publisher: Elsevier A new dimension of potential resources in innovation: A wider scope of patent claims can lead to new functionality development [An article from: Technovation] Offer Price: USD $10.95 Author: T. Saiki Publisher: Elsevier Novo Nordisk sues Sanofi-Aventis for insulin delivery device patent infringement.: An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Thomson Gale Virtual patent extension by cannibalization.: An article from: Southern Economic Journal Offer Price: USD $5.95 Author: Morton I. Kamien Publisher: Southern Economic Association Forest Laboratories and Lundbeck enter into settlement agreement with Alphapharm related to Lexapro patent litigation.: An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Thomson Gale

Developments in Pharmaceutical and Biotech Patent Law 2008 Offer Price: USD $368.00 Author: Daniel L. Reisner David K. Barr Publisher: Practising Law Institute Patents - why? Author: Ernst Jucker Publisher: Jucker Alnylam licenses gene silencing technology from Cold Spring Harbor.(Alnylam Pharmaceuticals, Inc., Cold Spring Harbor Laboratory ): An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News King Pharmaceuticals to license Skyepharma's delivery technology.: An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News Alnylam licenses gene silencing technology from Cold Spring Harbor.(Alnylam Pharmaceuticals Inc.)(Cold Spring Harbor Laboratory): An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News Introgen wins European patent decision on p53 gene therapeutic.: An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News Avigen granted gene therapy patent for intravenous delivery of Aav vectors.(Avigen Inc., adeno associated viruses)(Brief Article): An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News Stressgen obtains new European patent for heat shock protein fusions.(European Patent Office granted for heat shock proteins fused to antigens)(Brief Article): An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News Pharmaceutical Resources prevails in interference proceeding.(Pharmaceutical Resources Inc. wins patent lawsuit against Alpharma Inc.): An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News Generic take-up in the pharmaceutical market following patent expiry - A multi-country study Author: John Hudson Publisher: NP: Elsevier